Enrique Grande, Medical Oncology Department Director at Quironsalud Madrid, Adjunct Professor at The University of Texas MD Anderson Cancer Center, shared a post on X:
“Histological subtypes of urothelial carcinoma – micropapillary, plasmacytoid, sarcomatoid, squamous – don’t fit the one-size-fits-all treatment paradigm.
Each carries distinct biology, is often understaged on TURBT, and shows variable response to standard systemic therapy.”
Title: Histological Subtypes and Divergent Differentiation of Urothelial Carcinoma: Histology, Genomics, and Management Implications
Authors: Can Aydogdu, Laura Bukavina, Liang Cheng, Hikmat A. Al-Ahmadie, Omar Alhalabi, Jason R. Brown, Antonio Lopez-Beltran, Petros Grivas, Clara Hwang, G. Daniel Grass, Ashish M. Kamat, Jonathan Chatzkel, Omar Mian, Andrea Necchi, Jeff Ross, Andrea B. Apolo, Philippe E. Spiess, Roger Li.
Other articles about GU Oncology on OncoDaily.
